MXPA03005343A - Composiciones antiacidas liquidas. - Google Patents
Composiciones antiacidas liquidas.Info
- Publication number
- MXPA03005343A MXPA03005343A MXPA03005343A MXPA03005343A MXPA03005343A MX PA03005343 A MXPA03005343 A MX PA03005343A MX PA03005343 A MXPA03005343 A MX PA03005343A MX PA03005343 A MXPA03005343 A MX PA03005343A MX PA03005343 A MXPA03005343 A MX PA03005343A
- Authority
- MX
- Mexico
- Prior art keywords
- weight percent
- amount
- containing compounds
- liquid antacid
- glycerin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se proveen preparaciones antiacidas liquidas que comprenden: a) un compuesto activo neutralizante de acido seleccionado del grupo que consiste de compuestos que contienen calcio, compuestos que contienen aluminio, compuestos que contienen magnesio, y mezclas de los mismos; y b) un adyuvante antimicrobiano seleccionado del grupo que consiste de propilenglicol en una cantidad mayor de 2% en peso y menor de 15% en peso, glicerina en una cantidad de alrededor de 15 a aproximadamente 20% en peso, y combinaciones de propilenglicol en una cantidad de alrededor de 3 a aproximadamente 10% en peso con glicerina, en una cantidad de alrededor de 3 a aproximadamente 10% en peso con base en el peso total de la preparacion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/171,707 US20030232092A1 (en) | 2002-06-14 | 2002-06-14 | Liquid antacid compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03005343A true MXPA03005343A (es) | 2004-10-29 |
Family
ID=29717770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03005343A MXPA03005343A (es) | 2002-06-14 | 2003-06-13 | Composiciones antiacidas liquidas. |
Country Status (20)
Country | Link |
---|---|
US (1) | US20030232092A1 (es) |
EP (1) | EP1374874B1 (es) |
JP (1) | JP2004035551A (es) |
KR (1) | KR20030096085A (es) |
CN (1) | CN1470246A (es) |
AR (1) | AR039693A1 (es) |
AT (1) | ATE340582T1 (es) |
AU (1) | AU2003204688B2 (es) |
BR (1) | BR0302470A (es) |
CA (1) | CA2432231A1 (es) |
DE (1) | DE60308595T2 (es) |
ES (1) | ES2271483T3 (es) |
HU (1) | HUP0301715A2 (es) |
MX (1) | MXPA03005343A (es) |
NZ (1) | NZ526459A (es) |
PL (1) | PL360680A1 (es) |
PT (1) | PT1374874E (es) |
RU (1) | RU2322246C2 (es) |
SA (1) | SA03240232B1 (es) |
ZA (1) | ZA200304650B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080260823A1 (en) * | 2007-04-20 | 2008-10-23 | Sciele Pharma, Inc. | Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea |
RU2635276C1 (ru) | 2016-06-24 | 2017-11-09 | Акционерное общество "Лаборатория Касперского" | Безопасная аутентификация по логину и паролю в сети Интернет с использованием дополнительной двухфакторной аутентификации |
CN108721213A (zh) * | 2017-04-13 | 2018-11-02 | 辽宁大熊制药有限公司 | 铝镁混悬液及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL32020A (en) * | 1968-04-18 | 1972-11-28 | Brown G | Antacid compositions |
JPH0692309B2 (ja) * | 1986-11-22 | 1994-11-16 | 富士化学工業株式会社 | 懸濁制酸剤 |
WO1993011750A1 (en) * | 1991-12-17 | 1993-06-24 | Fuisz Technologies Ltd. | Ulcer prevention and treatment composition and method |
WO1994027577A1 (en) * | 1993-05-26 | 1994-12-08 | The Procter & Gamble Company | Liquid antacid compositions |
DE19529862A1 (de) * | 1995-08-14 | 1997-02-20 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
JP3615894B2 (ja) * | 1997-01-20 | 2005-02-02 | 株式会社ノエビア | 抗菌性低刺激化粧料 |
-
2002
- 2002-06-14 US US10/171,707 patent/US20030232092A1/en not_active Abandoned
-
2003
- 2003-06-13 PT PT03253733T patent/PT1374874E/pt unknown
- 2003-06-13 NZ NZ526459A patent/NZ526459A/en unknown
- 2003-06-13 PL PL03360680A patent/PL360680A1/xx not_active Application Discontinuation
- 2003-06-13 ES ES03253733T patent/ES2271483T3/es not_active Expired - Lifetime
- 2003-06-13 AT AT03253733T patent/ATE340582T1/de not_active IP Right Cessation
- 2003-06-13 ZA ZA200304650A patent/ZA200304650B/xx unknown
- 2003-06-13 EP EP03253733A patent/EP1374874B1/en not_active Expired - Lifetime
- 2003-06-13 HU HU0301715A patent/HUP0301715A2/hu unknown
- 2003-06-13 KR KR10-2003-0038274A patent/KR20030096085A/ko not_active Application Discontinuation
- 2003-06-13 JP JP2003169624A patent/JP2004035551A/ja active Pending
- 2003-06-13 AU AU2003204688A patent/AU2003204688B2/en not_active Ceased
- 2003-06-13 MX MXPA03005343A patent/MXPA03005343A/es active IP Right Grant
- 2003-06-13 CA CA002432231A patent/CA2432231A1/en not_active Abandoned
- 2003-06-13 DE DE60308595T patent/DE60308595T2/de not_active Expired - Fee Related
- 2003-06-16 RU RU2003117751/15A patent/RU2322246C2/ru not_active IP Right Cessation
- 2003-06-16 BR BR0302470-9A patent/BR0302470A/pt not_active IP Right Cessation
- 2003-06-16 CN CNA03149448XA patent/CN1470246A/zh active Pending
- 2003-06-17 AR ARP030102147A patent/AR039693A1/es not_active Application Discontinuation
- 2003-08-04 SA SA03240232A patent/SA03240232B1/ar unknown
Also Published As
Publication number | Publication date |
---|---|
DE60308595D1 (de) | 2006-11-09 |
EP1374874B1 (en) | 2006-09-27 |
ES2271483T3 (es) | 2007-04-16 |
RU2322246C2 (ru) | 2008-04-20 |
EP1374874A3 (en) | 2004-01-07 |
KR20030096085A (ko) | 2003-12-24 |
HU0301715D0 (en) | 2003-08-28 |
AU2003204688A1 (en) | 2004-01-15 |
EP1374874A2 (en) | 2004-01-02 |
JP2004035551A (ja) | 2004-02-05 |
PT1374874E (pt) | 2006-12-29 |
ATE340582T1 (de) | 2006-10-15 |
US20030232092A1 (en) | 2003-12-18 |
AU2003204688B2 (en) | 2008-04-10 |
ZA200304650B (en) | 2005-01-24 |
BR0302470A (pt) | 2004-08-24 |
SA03240232B1 (ar) | 2007-07-31 |
PL360680A1 (en) | 2003-12-15 |
DE60308595T2 (de) | 2007-08-09 |
NZ526459A (en) | 2004-11-26 |
HUP0301715A2 (hu) | 2005-07-28 |
CA2432231A1 (en) | 2003-12-14 |
CN1470246A (zh) | 2004-01-28 |
AR039693A1 (es) | 2005-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1100522A4 (en) | ADMINISTRATION OF ACTIVE SUBSTANCES BY PULMONARY TRACT | |
AR046933A1 (es) | Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea | |
BR0109251A (pt) | Formulação agrotécnica, e, uso de um ciclo-hexanopolicarboxato de di(isononila) | |
CA2172493A1 (en) | Use of angiotensin iii and analogs thereof in tissue repair | |
DK1157037T3 (da) | GCSF-konjugater | |
WO2005027895A3 (en) | Thyroid hormone analogs and methods of use in angiogenesis | |
CA2333601A1 (en) | Surfactant for use in external preparations for skin and external preparation for skin containing the same | |
TW200505411A (en) | A formulation for chemical peeling | |
WO2006060515A3 (en) | System for improved percutaneous absorption of skin benefiting agents | |
EP2767291A3 (en) | Treatment of glycogen storage disease type II | |
WO2005000241A3 (en) | Compositons and methods for topical administration | |
WO2005000248A3 (en) | Compositions and methods for skin conditioning | |
ES2173378T3 (es) | Material cristalino microporoso, procedimiento para su preparacion y su utilizacion en composiciones detergentes. | |
EP2065025A3 (en) | A preservative composition and its use, a method of preparing it and formulations containing it | |
MXPA03005343A (es) | Composiciones antiacidas liquidas. | |
GB2362103B (en) | Pharmaceutical compositions including alginates | |
WO2002100338A3 (en) | Compound and composition for delivering active agents | |
IL152328A (en) | Preparations containing a combination of defibrotide and one or more hematopoietic factors and their use | |
AU2003269871A1 (en) | Radiosensitizer composition containing n-acetylphytosphingosine analogs and n,n-dimethyl-phytosphingosine analogs as the active ingredients | |
WO2002005759A8 (de) | Dekorative kosmetische zubereitungen dialkylcarbonate und metalloxide enthaltend | |
BRPI0412453A (pt) | uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo | |
ES2152666T3 (es) | Compuesto para rehidratacion oral comprendiendo glutamina. | |
MXPA04006269A (es) | Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes. | |
MXPA04006675A (es) | Composicion farmaceutica que comprende glitazona y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes. | |
WO2005040105A3 (fr) | Nouveaux tensio-actifs et leurs applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |